2005
DOI: 10.1002/cbic.200500028
|View full text |Cite
|
Sign up to set email alerts
|

NMR in Pharmacokinetic and Pharmacodynamic Profiling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 74 publications
0
6
0
Order By: Relevance
“…20 In the subdomains IIA and IIIA, the specific drug binding sites-the warfarin site and the diazepam site-are located. [24][25][26][27][28] These binding sites are the binding areas for small heterocyclic or aromatic carboxylic acids. Generally, the size of the ligand and drug-BSA interactions and dye-BSA interactions is influenced by the chemical structure of the respective compounds or species (steric effects) as well as their charge and hydrophilicity, which are closely related.…”
Section: Discussionmentioning
confidence: 99%
“…20 In the subdomains IIA and IIIA, the specific drug binding sites-the warfarin site and the diazepam site-are located. [24][25][26][27][28] These binding sites are the binding areas for small heterocyclic or aromatic carboxylic acids. Generally, the size of the ligand and drug-BSA interactions and dye-BSA interactions is influenced by the chemical structure of the respective compounds or species (steric effects) as well as their charge and hydrophilicity, which are closely related.…”
Section: Discussionmentioning
confidence: 99%
“…P450-metabolizing enzymes are responsible for drug−drug interactions common to a significant number of drugs (). While the structural details for P450 inhibition are still under investigation , it is known that electrophilic compounds do inhibit this class of enzymes. This may involve electrophilic attack of the heme or the heme-coordinating cysteine to disrupt xenobiotic oxidation.…”
Section: Resultsmentioning
confidence: 99%
“…For these reasons, batteries of in vitro tests have been developed that correlate with a toxicological outcome but are rapid and cost-effective enough to enable the evaluation of hundreds or even thousands of compounds. Most of these in vitro tests attempt to assess the impact of a drug on particular proteins or biological pathways associated with toxicity [e.g., hERG channel binding , inhibition or induction of P450 enzymes , or mutagenicity ].…”
Section: Introductionmentioning
confidence: 99%
“…Compared to ITC, NMR gives a broader view of the dynamic of bindings at equilibrium and whether the interaction occurs on specific sites or solely causes HSA conformational changes without being attached [ 32 , 57 ]. In its infancy for studying PBUT interactions with proteins, 2-D NMR monitors all binding sites on the protein and quantitatively measures site-specific binding constants [ 58 , 59 ]. So far, only Li et al [ 32 ] have utilized this technique to identify potential secondary and tertiary structure changes in HSA while interacting with PBUTs using STD (saturated transfer difference) NMR to detect the intensity of bindings through an on-and-off induced magnetic field without affecting the unbonded toxins.…”
Section: Experimental Techniques Commonly Employedmentioning
confidence: 99%